Seminars in Nuclear Medicine
Volume 40, Issue 5 , Pages 332-337 , September 2010

Design of Clinical Trials

  • David Rollo, MD, PhD

      Affiliations

    • Cell>Point LLC, Centennial, CO
    • Corresponding Author InformationAddress reprint requests to David Rollo, MD, PhD, Cell>Point LLC, 7120 E. Orchard Rd., Suite 350, Centennial, CO 80111
  • ,
  • Sanjay Machado, MD

      Affiliations

    • Venn Life Sciences Ltd, Saint-Laurent, Quebec, Canada
  • ,
  • Mauro Ceschin

      Affiliations

    • Venn Life Sciences Ltd, Saint-Laurent, Quebec, Canada

References 

  1. Guidance for Industry E6 Good Clinical Practice: Consolidated Guidance, ICH. April 1996;
  2. Guidance for Industry E 10 Choices of Control Group and Related Issues in Clinical Trials, ICH. May 2001;
  3. Guidance for IRBs, Clinical Investigators, and Sponsors IRB Continuing Review After Clinical Investigation Approval, U.S. Department of Health and Human Services, Food and Drug Administration. January 2010;

PII: S0001-2998(10)00018-8

doi: 10.1053/j.semnuclmed.2010.03.003

Seminars in Nuclear Medicine
Volume 40, Issue 5 , Pages 332-337 , September 2010